Germantown, MD, United States of America

Charbel Moussa

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 1.2

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Charbel Moussa: Innovator in Neurodegenerative Disease Treatment

Introduction

Charbel Moussa is a prominent inventor based in Germantown, MD, specializing in innovative treatments for neurodegenerative and lysosomal storage disorders. With a total of five patents to his name, he has made significant contributions to the field of medical research.

Latest Patents

Moussa's latest patents include groundbreaking compositions and methods for treating neurodegenerative, myodegenerative, and lysosomal storage disorders. One of his notable patents provides compositions and methods for treating or preventing neurodegenerative diseases, myodegenerative diseases, prion diseases, or lysosomal storage diseases in a subject. Another patent focuses on methods of treating lysosomal storage disorders and promoting lysosomal clearance in one or more cells of a subject.

Career Highlights

Charbel Moussa is affiliated with Georgetown University, where he conducts research and develops innovative solutions for complex medical challenges. His work has garnered attention for its potential to improve the quality of life for individuals suffering from debilitating diseases.

Collaborations

Moussa collaborates with esteemed colleagues, including Christian Wolf and Balaraman Kaluvu, to advance research in his field. Their combined expertise enhances the potential for groundbreaking discoveries.

Conclusion

Charbel Moussa's contributions to the treatment of neurodegenerative and lysosomal storage disorders highlight his role as a leading inventor in medical innovation. His work continues to pave the way for new therapeutic approaches that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…